Shenzhen, China

Shijun He

This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Shenzhen Like Lighting Technology Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shijun He. Retrieved from https://idiyas.com/inventor/shijun-he

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Shijun He - Innovator in Autoimmune Disease Treatment

Introduction

Shijun He is an inventor based in Shanghai, China. He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. Although he currently holds no granted patents, his research and patent applications demonstrate his commitment to advancing medical science.

Latest Patent Applications

Shijun He's notable patent application is titled "Use of Naphthoquine Phosphate in Preparation of a Medicament for Treating Autoimmune Diseases." This application outlines the effectiveness of naphthoquine phosphate in alleviating symptoms associated with rheumatoid arthritis and systemic lupus erythematosus. The research indicates that intragastric administration of naphthoquine phosphate can significantly reduce joint redness, swelling, and deformities in mouse models. Additionally, it has been shown to lower levels of anti-double-stranded DNA antibodies and anti-nuclear antibodies. The findings suggest that naphthoquine phosphate possesses ideal immunosuppressive activity, making it a promising candidate for pharmaceutical compositions aimed at treating autoimmune diseases.

Conclusion

Shijun He is a dedicated inventor whose work focuses on innovative treatments for autoimmune diseases. His research on naphthoquine phosphate highlights the potential for new therapeutic options in this critical area of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…